-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Cardinal Health, Raises Price Target to $160

Benzinga·04/29/2025 14:29:58
Listen to the news
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $150 to $160.